On performing a microarray analysis of cytokines, chemokines, and receptors (Fig S3), we found that, among others, CXCL10 was up-regulated in Tα1-DC as compared with GM-DC and FL-DC, whereas CCL22 was apparently down-regulated (Fig 6G), consistent with the results obtained at the tumor site. The gene discussed is CCL22; the disease is neoplasm.